long-term effects of glp-1 for weight loss New research published by The Washington Post suggests that popular medications like Ozempic, commonly used diabetes and loss, may have a significant and devastating impact on bone GLP-1 Drugs and Weight Loss:

The glucagon receptor component drives energy expenditure and hepatic fat mobilisation, a mechanism absent in earlier-generation incretin compounds

The tradeoff is less real-time interaction with the reviewing clinician at the intake stage

The FDA recently approved one of these, elamipretide, for the treatment of a rare genetic mitochondrial disorder

Not every higher-C claim translates into meaningfully better real-world performance

Huang WJ, Lu XL, Li JT, Zhang JM

Pharmaceutical giant Eli Lilly saw its stock jump Thursday morning after announcing initial Phase 3 trial results on orforglipron, a highly anticipated medication for diabetes and weight loss